Shock, Traumatic
12
1
1
5
Key Insights
Highlights
Success Rate
63% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 74/100
25.0%
3 terminated out of 12 trials
62.5%
-24.0% vs benchmark
8%
1 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (12)
REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam
The AT-REBOA Target Trial
Transfusion for Major Haemorrhage in Trauma - Characteristics and Outcomes
Discriminant Ability of the Shock Index, Modified Shock Index, and Reverse Shock Index Multiplied by the Glasgow Coma Scale on Mortality in Adult Trauma Patients: A PATOS Study
Comparison of Ketamine and Etomidate During Rapid Sequence Intubation in Trauma Patients
Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury
Low Dose Vasopressin in Traumatic Shock
Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock Patients
Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock Patients
Polydatin Injectable (HW6) for Shock Treatment
Hypertonic Resuscitation Following Traumatic Injury
A Comparison of Two Target Mean Arterial Pressures in the Resuscitation of Hypotensive Trauma Patients